There were 1,654 press releases posted in the last 24 hours and 331,972 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image